Potential use of STAT3 inhibitors in targeted prostate cancer therapy: future prospects

por Shodeinde, Adetola L, Barton, Beverly E
Publicado 2012

Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells

por Huang, Hosea F, Murphy, Thomas F, Shu, Ping, Barton, Arnold B, Barton, Beverly E
Publicado 2005

IL-6 signaling by STAT3 participates in the change from hyperplasia to neoplasia in NRP-152 and NRP-154 rat prostatic epithelial cells

por Barton, Beverly E, Murphy, Thomas F, Adem, Patricia, Watson, Richard A, Irwin, Robert J, Huang, Hosea F
Publicado 2001

Creation of a novel peptide with enhanced nuclear localization in prostate and pancreatic cancer cell lines

por Lewis, H Dan, Husain, Ali, Donnelly, Robert J, Barlos, Dimitrios, Riaz, Sheraz, Ginjupalli, Kalyani, Shodeinde, Adetola, Barton, Beverly E
Publicado 2010